IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Pharmstandard International S.A.

Q2 2018 Holdings

Filed 2018-08-14 | 6 holdings | $24.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Allena Pharmaceuticals(ALNAEUR)Common018119107$11.4K878,13145.9%
Protagonist Therapeutics, Inc.(PTGX)Common74366E102$5.0K750,63220.2%
Jounce Therapeutics, Inc.(JNCEEUR)Common481116101$4.3K565,06317.4%
Proteon Therapeutics Inc.Common74371L109$3.9K1,607,80715.8%
Argos Therapeutics Inc.Common040221103$136826,1530.5%
Argos Therapeutics Inc.CallCommon040221103$42256,0300.2%